Nepal suspends sale of injection made by Indian company citing ‘serious health risks’

Scroll Staff

· Jun 20, 2024 · 02:52 pm

The story of a drug that India has failed to ban

Tabassum Barnagarwala

· Jan 04, 2024 · 06:30 am

Rush Hour podcast: Ashoka University professor who wrote 2019 election manipulation paper quits

Scroll Staff

· Aug 15, 2023 · 05:55 pm

Centre sets deadline for pharmaceutical firms to adopt WHO’s good manufacturing practices

Scroll Staff

· Aug 03, 2023 · 08:46 pm

Gambia tightens pharmaceutical quality checks for shipments from India

Scroll Staff

· Jun 23, 2023 · 03:00 pm

Drug regulators stop production at 18 firms in drive against spurious medicines

Scroll Staff

· Mar 28, 2023 · 08:26 pm

Uzbekistan children deaths: Marion Biotech’s manufacturing licence cancelled

Scroll Staff

· Mar 22, 2023 · 04:54 pm

India’s cough syrup testing regime has a deadly blind spot

Tabassum Barnagarwala

· Feb 02, 2023 · 06:30 am

Act immediately to protect children from contaminated medicines, WHO urges governments

Scroll Staff

· Jan 24, 2023 · 04:51 pm

How to deal with Omicron – and three other weekend reads

Supriya Sharma

· Dec 26, 2021 · 09:30 am

Few inspectors, no records: Drug regulation in India is hobbled by a number of problems

Swagata Yadavar, IndiaSpend.com

· Nov 18, 2019 · 01:30 pm

Supreme Court exempts Saridon from government’s ban on fixed dose combination drugs

Scroll Staff

· Sep 17, 2018 · 03:51 pm

Delhi High Court allows pharma major Wockhardt to sell its fixed dose combination drug till Tuesday

Scroll Staff

· Sep 14, 2018 · 08:29 pm

Delhi High Court allows pharma major Wockhardt to sell its fixed dose combination drug till Tuesday

Scroll Staff

· Sep 14, 2018 · 07:42 pm

Health ministry bans 328 fixed dose combination drugs with immediate effect

Scroll Staff

· Sep 13, 2018 · 10:47 am

Health ministry bans 328 fixed dose combination drugs with immediate effect

Scroll Staff

· Sep 13, 2018 · 09:26 am

Medical research council objects to the health ministry easing up on stem cell therapy regulation

Priyanka Vora

· May 07, 2018 · 02:30 pm

United States is approving drugs by the dozen. Why is it worrying Indian pharma companies?

Sriram Iyer, qz.com

· Jan 07, 2018 · 07:30 pm

Reality check: Forget clinical tests, there is no proper definition of what a new AYUSH drug is

Menaka Rao

· May 10, 2016 · 06:30 pm